Reprint of: The non-mammalian MIF superfamily |
| |
Affiliation: | 1. Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium;2. Myeloid Cell Immunology Lab, VIB-UGent Center for Inflammation Research, Ghent, Belgium;3. Amphibian Evolution Lab, Department of Biology, Vrije Universiteit Brussel (VUB), Brussels, Belgium;4. VIB Structural Biology Research Center, Brussels, Belgium;5. Laboratory for Biomedical Research, Ghent University Global Campus, Yeonsu-Gu, Incheon, South Korea;6. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA;1. Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp (UA), Antwerp 2610, Belgium;2. Laboratory of Cell Biology and Histology, University of Antwerp (UA), Antwerp 2020, Belgium;1. Department of Internal Medicine IV, Saarland University Medical Center, Homburg, Germany;2. Cardiovascular Research Unit, Luxembourg Institute of Health, Luxembourg;3. University Heart Center Luebeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Luebeck, Germany;4. GenXPro GmbH, Frankfurt/Main, Germany;5. EvA Study Center, Comprehensive Pneumology Center Helmholtz Zentrum Muenchen − German Research Center for Environmental Health, Gauting, Germany;1. Department of Immunology, Jagiellonian University Medical College, 18 Czysta St, PL 31-121 Krakow, Poland;2. Students’ Scientific Society, Department of Immunology, Jagiellonian University Medical College, 18 Czysta St, PL 31-121 Krakow, Poland;3. Students’ Scientific Society, Department of Pain Treatment and Palliative Care, Jagiellonian University Medical College, 10 Sniadeckich St, PL 31-531 Krakow, Poland;4. Department of Pain Treatment and Palliative Care, Jagiellonian University Medical College, 10 Sniadeckich St, PL 31-531 Krakow, Poland;1. Department of Medical Biotechnology, Faculty Of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland;2. Department of Clinical Immunology and Transplantology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland;3. AGH University of Science and Technology, Faculty of Metal Engineering and Industrial Computer Science, Department of Heat Engineering and Environment Protection, Poland;4. Department of Radioligands, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland |
| |
Abstract: | Macrophage migration inhibitory factor (MIF) was first described as a cytokine 50 years ago, and emerged in mammals as a pleiotropic protein with pro-inflammatory, chemotactic, and growth-promoting activities. In addition, MIF has gained substantial attention as a pivotal upstream mediator of innate and adaptive immune responses and with pathologic roles in several diseases. Of less importance in mammals is an intrinsic but non-physiologic enzymatic activity that points to MIF's evolution from an ancient defense molecule. Therefore, it is not surprising that mif-like genes also have been found across a range of different organisms including bacteria, plants, protozoa, helminths, molluscs, arthropods, fish, amphibians and birds. While Genebank analysis identifying mif-like genes across species is extensive, contained herein is an overview of the non-mammalian MIF-like proteins that have been most well studied experimentally. For many of these organisms, MIF contributes to an innate defense system or plays a role in development. For parasitic organisms however, MIF appears to function as a virulence factor aiding in the establishment or persistence of infection by modulating the host immune response. Consequently, a combined targeting of both parasitic and host MIF could lead to more effective treatment strategies for parasitic diseases of socioeconomic importance. |
| |
Keywords: | Macrophage migration inhibitory factor (MIF) Homology Immunity Parasitology |
本文献已被 ScienceDirect 等数据库收录! |
|